CN108558817A - A kind of isocoumarin analog derivative and its preparation method and application - Google Patents

A kind of isocoumarin analog derivative and its preparation method and application Download PDF

Info

Publication number
CN108558817A
CN108558817A CN201810288455.6A CN201810288455A CN108558817A CN 108558817 A CN108558817 A CN 108558817A CN 201810288455 A CN201810288455 A CN 201810288455A CN 108558817 A CN108558817 A CN 108558817A
Authority
CN
China
Prior art keywords
isocoumarin
analog derivative
methanol
preparation
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810288455.6A
Other languages
Chinese (zh)
Other versions
CN108558817B (en
Inventor
丁立建
何山
黄立明
崔巍
斯拉瓦·爱泼斯坦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Douhuangjin Food Co ltd
Shenzhen Dragon Totem Technology Achievement Transformation Co ltd
Original Assignee
Ningbo University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningbo University filed Critical Ningbo University
Priority to CN201810288455.6A priority Critical patent/CN108558817B/en
Publication of CN108558817A publication Critical patent/CN108558817A/en
Application granted granted Critical
Publication of CN108558817B publication Critical patent/CN108558817B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a kind of isocoumarin analog derivative and its preparation method and application, feature is the structural formula of the isocoumarin analog derivative as shown in I, and it is CCTCC No that preparation methods steps, which include by preserving number,:The marine fungi fermented and cultured of M2014086 obtains the fermentate containing isocoumarin analog derivative, then methanol is added and impregnates ultrasound filtration, it is evaporated, it is evaporated after being extracted with ethyl acetate again, obtain coarse extract, by the extract through depressurizing silica gel column chromatography, reverse phase medium pressure column chromatography, last half preparative high-performance liquid chromatographic of reverse phase isolates and purifies to obtain, the isocoumarin analog derivative has antioxidation, advantage, which is compound I, has Scavenging ability, is possibly used for the morbidity of delay Alzheimer disease and helps to alleviate its symptom.

Description

A kind of isocoumarin analog derivative and its preparation method and application
Technical field
The present invention relates to a kind of isocoumarin analog derivatives, more particularly, to a kind of isocoumarin analog derivative and its preparation Method and purposes.
Background technology
There is isocoumarin analog derivative anticancer, antibacterial, protease to inhibit and physiology and the bioactivity such as anti-oxidant.This hair A person of good sense is total to epiphytic fungi to spongeAspergillus ustus(It is preserved in China typical culture collection center, deposit number For:CCTCC No: M2014086)The ethyl acetate extract of solid fermentation has carried out anti-oxidant experiment, it is found that it is anti-oxidant it has Activity then studies its active constituent, a kind of isolated new isocoumarin analog derivative.Have not yet to see this The chemical constitution of compound and its report of antioxidant activity, therefore in the market also there is not yet drug related to this.
Invention content
Technical problem to be solved by the invention is to provide a kind of isocoumarin analog derivative with antioxidant activity and Preparation method and use.
Technical solution is used by the present invention solves above-mentioned technical problem:A kind of isocoumarin analog derivative, an unusually sweet smell The structural formula of legumin analog derivative is as shown in I:
(I).
The preparation method of above-mentioned isocoumarin analog derivative, specifically comprises the following steps:
(1)Fermenting and producing:It is CCTCC No by preserving number:The aspergillus ustus of M2014086(Aspergillus ustus)Scribing line It brings back to life, then chooses a single bacterium colony and be inoculated into PDB fluid nutrient mediums, under the conditions of 28 DEG C, 150rpm, conduct after culture 5 days Seed liquor;The ratio of seed liquor 5-20% by volume is inoculated into rice medium again, in 28 DEG C, is left to ferment 30 days;
(2)The acquisition of coarse extract:Methanol is added into the conical flask after fermentation, by solid immersion, ultrasound 15 minutes is stood overnight Afterwards, methanol extract liquid filtered through gauze is removed into solid residue;Solid residue is repeated after extracting 3-5 times, by methanol extract liquid It is evaporated removing methanol after merging, then uses water dissolution, adds and repeats extraction 5 times with the isometric ethyl acetate of aqueous solution, close And be concentrated under reduced pressure after extract liquor and remove ethyl acetate, obtain coarse extract;
(3)Compound isolates and purifies:After coarse extract dichloromethane and methanol mixed solvent dissolving, add 200-300 mesh silicon Glue mixes sample, uses volume ratio for 2:1 petrol ether/ethyl acetate is eluant, eluent, and decompression silica gel column chromatography is carried out to coarse extract, is received Collect elution fraction;It uses dichloromethane and methanol mixed solvent for eluant, eluent, gel filtration chromatography is carried out to elution fraction(LH- 20), collect elution fraction;By elution fraction using compression leg chromatographic isolation in reverse phase, use first alcohol and water for eluant, eluent, gradient It is from volume fraction 30% methanol linear elution to 100% methanol, elution time is 120 minutes, and flow velocity 20mL/min is collected out The flow point that peak time is 80-90 minutes, finally partly preparation reversed-phase high performance liquid chromatography isolates and purifies to obtain an unusually sweet smell beans flow point warp Plain analog derivative, structure are shown in formula I:
(I).
The formula of the PDB fluid nutrient mediums is as follows:Potato 200g, glucose 20g, sea crystal 35g and distillation Water 1L;The formula of the rice medium is as follows:Rice 100g, sea crystal 3.5g and 100 mL of distilled water.
The volume ratio of dichloromethane and methanol is 1 in the dichloromethane and methanol mixed solvent:1.
Described half eluent for preparing reversed-phase high performance liquid chromatography is acetonitrile and water by volume 28:72 mix.
The application of above-mentioned isocoumarin analog derivative, the isocoumarin analog derivative is in terms of preparing antioxidant Purposes.
Compared with the prior art, the advantages of the present invention are as follows:A kind of isocoumarin analog derivative of the present invention and its preparation side Method and purposes obtain the fermentate of the aromatic compounds containing chlorine by microbial fermentation culture, then by fermentate methanol Impregnate, ethyl acetate extraction, obtain coarse extract, by the coarse extract through depressurize silica gel column chromatography, gel filtration chromatography, medium pressure column chromatography and Half preparative high-performance liquid chromatographic of reverse phase isolates and purifies to obtain, which can be as with antioxidation New drug ingredient or lead compound;The present invention obtains isocoumarin analog derivative by microbial fermentation, and operating procedure is simple, raw The production period is short, product cost is low feature and environmentally safe.
Above-mentioned aspergillus ustus(Aspergillus ustus), which is DJ003 bacterial strains, and deposit number is CCTCC No. M2014086, China typical culture collection center was preserved on 03 14th, 2014, and preservation address is the China Wuhan military Chinese university.
Description of the drawings
Fig. 1 is that chemical compounds I removes DPPH free radicals with concentration dependant manner.Chemical compounds I or vitamin C(VitC)To refer to Determine concentration to be added in 0.2mM DPPH solution 20 minutes, DPPH free radicals are measured by evaluating the absorbance at 517nm Content, data indicate the average value ± SEM individually tested three times;Relative to control group * * p<0.01(ANOVA and Duncet examinations It tests).
Specific implementation mode
Below in conjunction with attached drawing embodiment, present invention is further described in detail.
Embodiment 1
A kind of isocoumarin analog derivative structural formula is as shown in I:
(I).
Embodiment 2
The preparation method of isocoumarin analog derivative as shown in I formulas, steps are as follows:
(1)Fermenting and producing:It is CCTCC No by preserving number:The aspergillus ustus of M2014086(Aspergillus ustus)Scribing line It brings back to life, then chooses a single bacterium colony and be inoculated into PDB fluid nutrient mediums, under the conditions of 28 DEG C, 150rpm, conduct after culture 5 days Seed liquor;The ratio of seed liquor 5-20% by volume is inoculated into rice medium again, in 28 DEG C, is left to ferment 30 days;Its The formula of middle PDB fluid nutrient mediums is as follows:Potato 200g, glucose 20g, sea crystal 35g and distilled water 1L;Described is big The formula of rice culture medium is as follows:Rice 100g, sea crystal 3.5g and 100 mL of distilled water;
(2)The acquisition of coarse extract:Methanol is added into the conical flask after fermentation, by solid immersion, ultrasound 15 minutes is stood overnight Afterwards, methanol extract liquid filtered through gauze is removed into solid residue;Solid residue is repeated after extracting 3-5 times, by methanol extract liquid It is evaporated removing methanol after merging, then uses water dissolution, adds and repeats extraction 5 times with the isometric ethyl acetate of aqueous solution, close And be concentrated under reduced pressure after extract liquor and remove ethyl acetate, obtain coarse extract;
(3)Compound isolates and purifies:After coarse extract dichloromethane and methanol mixed solvent dissolving, add 200-300 mesh silicon Glue mixes sample, uses volume ratio for 2:1 petrol ether/ethyl acetate is eluant, eluent, and decompression silica gel column chromatography is carried out to coarse extract, is received Collect elution fraction;It uses dichloromethane and methanol mixed solvent for eluant, eluent, gel filtration chromatography is carried out to elution fraction(LH- 20), collect elution fraction;By elution fraction using compression leg chromatographic isolation in reverse phase, use first alcohol and water for eluant, eluent, gradient It is from volume fraction 30% methanol linear elution to 100% methanol, elution time is 120 minutes, and flow velocity is 20mL/min, is collected The flow point that appearance time is 80-90 minutes, finally partly preparation reversed-phase high performance liquid chromatography isolates and purifies to obtain an unusually sweet smell flow point warp Legumin analog derivative, structure are shown in formula I:
(I).
The volume ratio of dichloromethane and methanol is 1 wherein in dichloromethane and methanol mixed solvent:1;Half prepares reverse phase height The eluent of effect liquid phase chromatogram is acetonitrile and water by volume 28:72 mix.
The chemical compounds I aubergine powder, molecular formula C14H18O5, [α]=-23.83 (c 0.2, CHCl3), cation HRESIMS m/z:284.1490[M+NH4]+,1H and13C-NMR data are shown in Table 1.
1 chemical compounds I of table1H and13C NMR datas (600 and 150MHz, in DMSO-d6)a
Note:This table signals assignment be based on DEPT,1H-1H COSY, HSQC and HMBC spectrum analysis results.Hydrogen signal multiplicity point It Yong not s (singlet), d (doublet), t (triplet) and m (multiplet) table.
Embodiment 3
The test of antioxidation activity in vitro(Free-radical scavenging activity is tested)
(1)Laboratory sample
The preparation of sample solution:Test sample is the chemical compounds I sterling isolated and purified in above-described embodiment 2, and precision weighs Appropriate amount of sample, for surveying activity.
(2)Experimental method
The antioxidant properties for determining chemical compounds I are measured by DPPH radicals scavengings.The drug of various concentration is added to DPPH Methanol solution(0.2mM)In.By mixture(200 holes μ L/)It is added in 96 orifice plates, and shakes 20 minutes at room temperature.Use enzyme Mark instrument measures absorbance at 517nm.Use vitamin C as positive control.DPPH free radical scavenging activities are calculated using following formula: DPPH free radical scavenging activities(%)=[(The absorbance of absorbance-sample of control)The absorbance of/control] × 100.
(3)Experimental result
In the test that chemical compounds I removes free radical.Chemical compounds I or vitamin C(VitC)It is added to 0.2mM with prescribed concentration 20 minutes in DPPH solution, the content of DPPH free radicals is measured by evaluating the absorbance at 517nm.As shown in Figure 1, chemical combination The content for reducing to I concentration dependent of object DPPH free radicals shows that chemical compounds I may be used as effective antioxidant, tables of data Show the average value ± SEM individually tested three times, relative to control group * * p<0.01(ANOVA and Duncet experiments).Chemical compounds I Effective antioxidation may be due to its hydroxyl.Many antioxidants potentially contribute to postpone such as vitamin C and vitamin E Alzheimer disease(AD)Morbidity and help to alleviate its symptom.Therefore, chemical compounds I, which is used as, has strong radicals scavenging The isocoumarin analog derivative of energy, it can also be used to the treatment of AD.
Above description is not limitation of the present invention, and the present invention is also not limited to the example above.The art it is common Technical staff is in the essential scope of the present invention, the variations, modifications, additions or substitutions made, and should also belong to the protection of the present invention Range.

Claims (6)

1. a kind of isocoumarin analog derivative, it is characterised in that the structural formula of the isocoumarin analog derivative is as shown in I:
(I).
2. a kind of preparation method of isocoumarin analog derivative according to claim 1, it is characterised in that specifically include as Lower step:
(1)Fermenting and producing:It is CCTCC No by preserving number:The aspergillus ustus of M2014086(Aspergillus ustus)Scribing line It brings back to life, then chooses a single bacterium colony and be inoculated into PDB fluid nutrient mediums, under the conditions of 28 DEG C, 150rpm, conduct after culture 5 days Seed liquor;The ratio of seed liquor 5-20% by volume is inoculated into rice medium again, in 28 DEG C, is left to ferment 30 days;
(2)The acquisition of coarse extract:Methanol is added into the conical flask after fermentation, by solid immersion, ultrasound 15 minutes is stood overnight Afterwards, methanol extract liquid filtered through gauze is removed into solid residue;Solid residue is repeated after extracting 3-5 times, by methanol extract liquid It is evaporated removing methanol after merging, then uses water dissolution, adds and repeats extraction 5 times with the isometric ethyl acetate of aqueous solution, close And be concentrated under reduced pressure after extract liquor and remove ethyl acetate, obtain coarse extract;
(3)Compound isolates and purifies:After coarse extract dichloromethane and methanol mixed solvent dissolving, add 200-300 mesh silicon Glue mixes sample, uses volume ratio for 2:1 petrol ether/ethyl acetate is eluant, eluent, and decompression silica gel column chromatography is carried out to coarse extract, is received Collect elution fraction;It uses dichloromethane and methanol mixed solvent for eluant, eluent, gel filtration chromatography is carried out to elution fraction, collection is washed De- component;By elution fraction using compression leg chromatographic isolation in reverse phase, use first alcohol and water for eluant, eluent, gradient is from volume point For several 30% methanol linear elutions to 100% methanol, elution time is 120 minutes, flow velocity 20mL/min, collects appearance time and is 80-90 minutes flow points, finally partly preparation reversed-phase high performance liquid chromatography isolates and purifies to obtain isocoumarin class derivative flow point warp Object, structure are shown in formula I:
(I).
3. a kind of preparation method of isocoumarin analog derivative according to claim 2, it is characterised in that the PDB liquid The formula of body culture medium is as follows:Potato 200g, glucose 20g, sea crystal 35g and distilled water 1L;The rice culture The formula of base is as follows:Rice 100g, sea crystal 3.5g and distilled water 100mL.
4. a kind of preparation method of isocoumarin analog derivative according to claim 2, it is characterised in that the dichloro The volume ratio of dichloromethane and methanol is 1 in methane and methanol mixed solvent:1.
5. the preparation method of isocoumarin analog derivative according to claim 2, it is characterised in that:Described half prepares anti- The eluent of phase high performance liquid chromatography is acetonitrile and water by volume 28:72 mix.
6. a kind of application of isocoumarin analog derivative according to any one of claims 1-5, it is characterised in that:It is described Purposes of the isocoumarin analog derivative in terms of preparing antioxidant.
CN201810288455.6A 2018-03-30 2018-03-30 Isocoumarin derivative and preparation method and application thereof Active CN108558817B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810288455.6A CN108558817B (en) 2018-03-30 2018-03-30 Isocoumarin derivative and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810288455.6A CN108558817B (en) 2018-03-30 2018-03-30 Isocoumarin derivative and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN108558817A true CN108558817A (en) 2018-09-21
CN108558817B CN108558817B (en) 2021-07-09

Family

ID=63533751

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810288455.6A Active CN108558817B (en) 2018-03-30 2018-03-30 Isocoumarin derivative and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN108558817B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110483467A (en) * 2019-07-11 2019-11-22 宁波大学 Dihydroiso-coumarin analog derivative and its preparation method and application
CN111592989A (en) * 2020-06-28 2020-08-28 曲靖师范学院 Aspergillus sp.G12 and method for preparing isocorydine alkali by fermenting Aspergillus sp.G12
CN113061631A (en) * 2021-03-31 2021-07-02 华中科技大学 Isochroman derivative and enzymatic synthesis method and application thereof
CN116178390A (en) * 2021-11-26 2023-05-30 北京中医药大学东直门医院 Dihydrothiophene heterozygous isocoumarin compound with circularly polarized fluorescence and application thereof
CN116650475A (en) * 2023-04-24 2023-08-29 福建中医药大学 Application of isocoumarin derivative diaorthothin in preparation of medicine with neuroprotective function

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000002860A1 (en) * 1998-07-08 2000-01-20 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
CN102659746A (en) * 2012-04-19 2012-09-12 山东省医学科学院药物研究所 Ailanthus flower extract as well as preparation method and application of active ingredients brevifolin of ailanthus flower extract
CN103570665A (en) * 2012-07-23 2014-02-12 中国药科大学 Enantiomers of 3-methyl-7, 8-dihydroxy-isochroman-4-one, and applications thereof in controlling cardiovascular diseases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000002860A1 (en) * 1998-07-08 2000-01-20 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
CN102659746A (en) * 2012-04-19 2012-09-12 山东省医学科学院药物研究所 Ailanthus flower extract as well as preparation method and application of active ingredients brevifolin of ailanthus flower extract
CN103570665A (en) * 2012-07-23 2014-02-12 中国药科大学 Enantiomers of 3-methyl-7, 8-dihydroxy-isochroman-4-one, and applications thereof in controlling cardiovascular diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KAMOLCHANOK TIANPANICH, ET AL.: "Radical Scavenging and Antioxidant Activities of Isocoumarins and a Phthalide from the Endophytic Fungus Colletotrichum sp.", 《J. NAT. PROD.》 *
SENHUA CHEN,ET AL.: "Isocoumarins and benzofurans from the mangrove endophytic fungus Talaromyces amestolkiae possess a-glucosidase inhibitory and antibacterial activities", 《RSC ADV.》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110483467A (en) * 2019-07-11 2019-11-22 宁波大学 Dihydroiso-coumarin analog derivative and its preparation method and application
CN110483467B (en) * 2019-07-11 2023-01-03 宁波大学 Dihydroisomerin derivative and preparation method and application thereof
CN111592989A (en) * 2020-06-28 2020-08-28 曲靖师范学院 Aspergillus sp.G12 and method for preparing isocorydine alkali by fermenting Aspergillus sp.G12
CN113061631A (en) * 2021-03-31 2021-07-02 华中科技大学 Isochroman derivative and enzymatic synthesis method and application thereof
CN116178390A (en) * 2021-11-26 2023-05-30 北京中医药大学东直门医院 Dihydrothiophene heterozygous isocoumarin compound with circularly polarized fluorescence and application thereof
CN116178390B (en) * 2021-11-26 2024-05-14 北京中医药大学东直门医院 Dihydrothiophene heterozygous isocoumarin compound with circularly polarized fluorescence and application thereof
CN116650475A (en) * 2023-04-24 2023-08-29 福建中医药大学 Application of isocoumarin derivative diaorthothin in preparation of medicine with neuroprotective function

Also Published As

Publication number Publication date
CN108558817B (en) 2021-07-09

Similar Documents

Publication Publication Date Title
CN108558817A (en) A kind of isocoumarin analog derivative and its preparation method and application
CN107298671A (en) Come from the secalonic acid H of penicillium oxalicum and prepare the application of anti-human colon cancer drug
CN106946766B (en) Alkaloid compound and its extraction separation method in purslane
US20170360802A1 (en) Enrichment Method of Ergosterol Peroxide from Sporoderm-Broken Ganoderma Lucidum Spore Powder
CN107298672A (en) The secalonic acid I for coming from penicillium oxalicum is preparing the application of anti-human colon cancer drug
CN106518643B (en) A kind of cyclopentene ketone compounds and its preparation method and application
CN107353274A (en) Come from the secalonic acid I of penicillium oxalicum and prepare the application of anti-human oesophagus cancer drug
CN106166119A (en) Use of 3&#39; -hydroxygenistein for preparing composition for inhibiting melanin generation
CN110863021B (en) Preparation method and application of cytochalasin compound
CN106967024B (en) A kind of α-pyrone derivative and its preparation method and application
CN109337953B (en) Inonotus obliquus D extract and preparation method and detection method thereof
CN107298670A (en) Come from penicillium oxalicum secalonic acid H and prepare anti-human oral cavity epidermoid carcinoma medicinal application
CN110003152A (en) 2 (5H)-furanone based derivatives of one kind and its preparation method and application
CN109503414A (en) One kind alkane type sesquiterpene derivative of flores aurantii containing azo-cycle and its preparation and application
CN107298669B (en) Selenolonic acid I from penicillium oxalicum and application of medicine for resisting human oral epidermoid carcinoma
CN110862371B (en) Polycyclic polyketone compound, preparation method thereof and application thereof in preparation of antibacterial drugs
CN109045020A (en) The purposes of Aspergillus terreus secondary metabolite extract
CN110183418B (en) Sesquiterpene from mountain pepper plant root and separation method and application thereof
CN101481379B (en) Compound separated from acetic acid ethyl ester extract of ginko endogenetic fungal bacterial strain fermentation liquor
CN114276966B (en) Astragalus endophytic bacterium for producing isoflavone component and application thereof
CN107739361B (en) Derived from aspergillus versicolor anthraquinone analog compound and prepare the application of anti-human colon cancer drug
CN110003153A (en) A kind of benzofuran compounds and its preparation method and application
CN108707090A (en) One kind aromatic compound containing chlorine and its preparation method and application
CN106565639B (en) A kind of tetrahydrofurans and its preparation method and application
CN106478399B (en) Derivative in hydroxy anthraquinones category and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20221115

Address after: 276000 Shangye Town Industrial Park, Fei County, Linyi City, Shandong Province (north of the expressway exit)

Patentee after: DOUHUANGJIN FOOD Co.,Ltd.

Address before: Room 2202, 22 / F, Wantong building, No. 3002, Sungang East Road, Sungang street, Luohu District, Shenzhen City, Guangdong Province

Patentee before: Shenzhen dragon totem technology achievement transformation Co.,Ltd.

Effective date of registration: 20221115

Address after: Room 2202, 22 / F, Wantong building, No. 3002, Sungang East Road, Sungang street, Luohu District, Shenzhen City, Guangdong Province

Patentee after: Shenzhen dragon totem technology achievement transformation Co.,Ltd.

Address before: 315211, Fenghua Road, Jiangbei District, Zhejiang, Ningbo 818

Patentee before: Ningbo University